Ridge Splitting Using Autogenous Bone Wedge Versus the Conventional Intercortical Augmentation Technique in Horizontally Deficient Anterior Maxilla
Launched by CAIRO UNIVERSITY · Jul 26, 2024
Trial Information
Current as of May 07, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at two different methods for improving the bone width in the front part of the upper jaw, specifically for patients who have lost some bone in that area. The researchers want to find out which method works better: using a wedge of bone taken from the patient's own body (called an autogenous bone wedge) or using a mix of bone particles. This study is important because having enough bone width is crucial for successful dental implants and for achieving a good appearance.
To be eligible for the trial, participants should have some missing teeth in the front of their upper jaw and a certain amount of bone height and width. They also need to be generally healthy and free from conditions that could interfere with healing. If you join the study, you’ll receive one of the two treatments and will be monitored to see how your bone responds over time. This research could help improve treatments for people who need dental work in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. All patients possessed partially edentulous anterior maxillary ridge with the following criteria
- • 1. The anterior maxillary vertical dimension was more than ten mm measured from the alveolar crest to the basal bone of the maxilla.
- • 2. The horizontal alveolar dimension varies from 3-5 mm at the crest and 6-8 mm at the basal part of the ridge measured from the labial cortex to the lingual cortex.
- • 2. All patients were free from any medical conditions that may affect bone healing .
- • 3. No local pathosis that may interfere with bone healing.
- • 4. No previous grafting procedures at the indicated edentulous ridge.
- • -
- Exclusion Criteria:
- • 1- Patients suffering from any systemic disease that may affect bone healing. 2- Patients with less than 3mm labio palatal alveolar ridge width. 3- Ridge with inadequate vertical bone height. 4- Presence of any local pathosis that may interfere with bone healing. 5- Patients unable to continue the whole follow up.
- • -
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, , Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported